Cetuximab (anti-EGFR)
Cetuximab (anti-EGFR) (A2000-GRP)
Products
Description
Cetuximab, a novel molecular-targeted agent,is an inhibitor of EGFR monoclonal humanized antibody interacting with the extracellular binding site of EGFR to block ligand stimulation. MW：145.781 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2000 |
| Target | EGFR |